Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maxime Gauberti
Preclinical Evidence Toward the Use of Ketamine for Recombinant Tissue-Type Plasminogen Activator-Mediated Thrombolysis Under Anesthesia or Sedation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging
Theranostics
Medicine
Toxicology
Pharmaceutics
Pharmacology
Related publications
Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.
Journal of Pharmacobio-Dynamics
Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator
Surgery for Cerebral Stroke
Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator During Early Postpartum Period: A Review of the Literature
Acta Obstetricia et Gynecologica Scandinavica
Medicine
Gynecology
Obstetrics
Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
The Tissue-Type Plasminogen Activator Story
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients Over 80 Years Old: The Fukuoka Stroke Registry
PLoS ONE
Multidisciplinary
Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).
The Japanese Journal of Pharmacology